Will Core Scientific stock continue its decline amid persistent downward momentum?

Will Core Scientific stock continue its decline amid persistent downward momentum?
Core Scientific slides 4.7% to $13.78

Core Scientific (CORZ) stock is trading at $13.78, down 4.7% for the session and positioned below its key moving averages. The asset is currently experiencing notable intraday volatility amid persistent downward momentum.

CORZ price prediction
24H 1.85%
$13.73
48H 1.78%
$13.72
7D -3.49%
$13.01
1M -13.13%
$11.71
3M -19.66%
$10.83
6M -20.18%
$10.76
12M -22.33%
$10.47
Current price: $13.48 -0.8350 5.83%
Closed 10/16
Daily range 13.51 Arrow from to Icon 14.48
Weekly range 12.37 Arrow from to Icon 15.46
Loading...

Highlights

  • Core Scientific acquired Polaris DS LLC and secured $600 million in senior secured credit facilities to boost operational scale and liquidity.
  • The company named Jay Elms as Chief Commercial Officer and will announce fiscal Q3 2026 results before market open on November 5, 2026.
  • Shares of Core Scientific closed down 4.7% at $13.78, remaining in a bearish trend with expected consolidation between $12.37 to $15.52.

Liquidity and leadership moves as stock faces persistent weakness

Core Scientific recently completed its acquisition of Polaris DS LLC, expanding its operational scale and potentially enhancing company efficiency, according to Businesswire. The company also reinforced its liquidity position by entering into $600 million of committed senior secured credit facilities, including both a $100 million revolving credit facility and a $500 million letter of credit facility, as reported by Businesswire. Additionally, Core Scientific announced that it will release its third quarter fiscal year 2026 financial results prior to market open on November 5, 2026, and appointed Jay Elms as Chief Commercial Officer to further strengthen its leadership team. These corporate developments have occurred against a backdrop of sustained downward movement in the stock price.

Core Scientific asset chart
Core Scientific price dynamics. Source: TradingView.

Momentum signals deteriorate as technical levels reinforce downside

On the hourly chart, CORZ is trading below the MA-20 and MA-50, while the daily timeframe shows the price remains beneath the MA-200 level. The Ichimoku Kijun on the daily chart sits at $13.91 and serves as immediate resistance. Momentum indicators are negative overall—MACD has generated a strong sell signal and ADX confirms a selling trend, with RSI also indicating sell conditions. Meanwhile, Stochastic RSI and CCI are both neutral, highlighting mixed views about possible oversold extremes. Bull/Bear Power suggests buyers remain active despite broader weakness, and the Awesome Oscillator offers a neutral signal.

Downside risk prevails as price consolidates near support thresholds

Over the next two to three trading days, CORZ is expected to consolidate within a volatile range between $12.37 and $15.52. The probability of an upward move is very low, while a further decline is much more likely based on current conditions. The baseline scenario involves price consolidation around the current levels; a break above $13.91 would be required to shift toward a bullish pattern, while a slide below support near $12.37 could trigger additional downside.

Viktoras Karapetjanc, expert at Traders Union, sees Core Scientific making solid fundamental moves with the Polaris DS LLC acquisition and strengthened liquidity position. He notes that the market has yet to price in these strategic steps, with sentiment still weighed by the recent stock decline and technical weakness. The upcoming financial results and new commercial leadership are positive catalysts that could change momentum if execution is strong. However, near-term volatility and downside risk remain elevated. "If Core Scientific can deliver on operational improvements while maintaining financial flexibility, I expect sentiment and price action to gradually turn more constructive."

Earlier, analysts noted that Core Scientific's stock was experiencing persistent technical weakness and downside risks. This view is reinforced by the current article, as continued negative momentum and volatile price action underscore support near $12.37 as a critical level to monitor for potential further declines.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.